{
  "relevance_rule": {
    "rule_text": "All abstracts that have client provided keywords",
    "approach": "keywords",
    "key_concepts": {
      "keywords": [
        "Hyperphosphatemia",
        "Parathyroid hormone",
        "Calcitriol",
        "Chronic kidney disease",
        "ESRD",
        "Phosphate binder",
        "Sevelamer",
        "sucroferric oxyhydroxide",
        "lanthanum carbonate",
        "Ferric citrate",
        "Calcium acetate",
        "Constipation",
        "Tenapanor",
        "Claudins",
        "FGF receptor",
        "Albuminuria",
        "nicotinamide",
        "vitamin D",
        "SGLT2 inhibitors",
        "canagliflozin",
        "Dapagliflozin",
        "Empagliflozin",
        "Ozempic",
        "Calcium carbonate",
        "Serum phosphate",
        "Phosphate",
        "Fibroblast growth factor 23",
        "Hemodialysis",
        "Dialysis",
        "Dialysis Outcomes and Practice Patterns Study",
        "Sodium hydrogen transport exchanger 3",
        "sodium-dependent phosphate cotransporter 2b",
        "KDIGO",
        "KDOQI",
        "Sodium",
        "Phosphorus",
        "Klotho",
        "Tight junctions",
        "Occludins",
        "Vascular calcification",
        "Bristol Stool Form Scale",
        "Interdialytic weight gain",
        "peritoneal dialysis",
        "NTX1942",
        "SLC34A2",
        "Glomerular",
        "CKD-MBD",
        "Smooth muscle calcification",
        "Oxylanthanum carbonate"
      ],
      "categories": [],
      "contextual_concepts": []
    },
    "reasoning": "Explicitly stated as the relevance rule and matches client provided keywords."
  },
  "priority_rules": [
    {
      "priority": "High",
      "rule_text": "Phase 2 data, Phase 3 data (including meta-analyses), real-world data (including PROs and registry data), Phosphate binders/phosphate lowering treatment",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Phase 2",
          "Phase II",
          "Phase 3",
          "Phase III",
          "meta-analysis",
          "real-world data",
          "patient reported outcomes",
          "PROs",
          "registry data",
          "Phosphate binder",
          "phosphate lowering treatment"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Direct keyword matching for phases, data types, and treatments; highest priority so no exclusions."
    },
    {
      "priority": "Internal",
      "rule_text": "Ardelyx sponsored abstracts",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Ardelyx"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [
        "Phase 2",
        "Phase II",
        "Phase 3",
        "Phase III",
        "meta-analysis",
        "real-world data",
        "patient reported outcomes",
        "PROs",
        "registry data",
        "Phosphate binder",
        "phosphate lowering treatment"
      ],
      "reasoning": "Sponsor-based keyword; must exclude all High priority keywords for mutual exclusivity."
    },
    {
      "priority": "Medium",
      "rule_text": "Phase 1 data, retrospective analyses, prognostic studies, trial designs, preclinical studies; studies with trial outcomes and endpoints; other general studies",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Phase 1",
          "Phase I",
          "retrospective analysis",
          "retrospective study",
          "prognostic study",
          "trial design",
          "preclinical study",
          "trial outcomes",
          "endpoints",
          "general study"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [
        "Phase 2",
        "Phase II",
        "Phase 3",
        "Phase III",
        "meta-analysis",
        "real-world data",
        "patient reported outcomes",
        "PROs",
        "registry data",
        "Phosphate binder",
        "phosphate lowering treatment",
        "Ardelyx"
      ],
      "reasoning": "Keyword-based for study types; excludes all High and Internal priority keywords for exclusivity."
    },
    {
      "priority": "Low",
      "rule_text": "All abstracts that only have mention of an indication and does not include any other data",
      "approach": "context",
      "key_concepts": {
        "keywords": [],
        "categories": [],
        "contextual_concepts": [
          "mention of indication only",
          "no data presented",
          "no study results",
          "no endpoints",
          "no trial phase"
        ]
      },
      "exclusions": [
        "Phase 2",
        "Phase II",
        "Phase 3",
        "Phase III",
        "meta-analysis",
        "real-world data",
        "patient reported outcomes",
        "PROs",
        "registry data",
        "Phosphate binder",
        "phosphate lowering treatment",
        "Ardelyx",
        "Phase 1",
        "Phase I",
        "retrospective analysis",
        "retrospective study",
        "prognostic study",
        "trial design",
        "preclinical study",
        "trial outcomes",
        "endpoints",
        "general study"
      ],
      "reasoning": "Requires semantic/contextual understanding to identify abstracts with only indication mention and no data; excludes all higher priorities."
    }
  ]
}